Templeton is looking to launch a biotechnology and an aggressively managed US Growth fund in the sec...
Templeton is looking to launch a biotechnology and an aggressively managed US Growth fund in the second quarter of this year, writes James Thorneley. The funds will form part of the group's existing Oeic and will be similar to portfolios already being run in the US by Franklin Templeton. The $95m Franklin Aggressive Growth fund was launched in the US last June. A $10,000 investment then would be worth $23,000 as at 31 December, according to the group. The fund invests primarily in equity demonstrating accelerating growth, increasing profitability, or above average growth. The portfolio...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes